<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03018171</url>
  </required_header>
  <id_info>
    <org_study_id>01.17</org_study_id>
    <nct_id>NCT03018171</nct_id>
  </id_info>
  <brief_title>Intrathecal Clonidine Addiction for Combined Spinal Epidural Analgesia During Labor</brief_title>
  <acronym>ICA</acronym>
  <official_title>Impact on Maternal and Fetal Wellbeing and on Labor Curve of Intrathecal Clonidine Addiction for Labor Analgesia. A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>San Giovanni Calibita Fatebenefratelli Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>San Giovanni Calibita Fatebenefratelli Hospital</source>
  <brief_summary>
    <textblock>
      The study aims to evaluate the impact of the addition of 20 mcg of intrathecal clonidine in
      combined spinalepidural for labor analgesia on the local anesthetic consumption, on labor
      performance and on maternal fetal well-being.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>local anesthetic consumption reduction</measure>
    <time_frame>8 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">268</enrollment>
  <condition>Labor Pain</condition>
  <arm_group>
    <arm_group_label>SC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>this arm will receive intrathecal clonidine addiction to sufentanil during combined spinal epidural analgesia for labor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>S</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>this arm will receive intrathecal sufentanil during combined spinal epidural analgesia for labor</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clonidine</intervention_name>
    <description>Intrathecal clonidine addiction</description>
    <arm_group_label>SC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sufentanil</intervention_name>
    <description>Intrathecal</description>
    <arm_group_label>S</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written maternal informed consent

          -  Singleton pregnancy

          -  Gestational age ≥ 37 weeks,

          -  ASA I

          -  BMI &lt; 30

          -  fetus in cephalic presentation

        Exclusion Criteria:

          -  Suspect or certainty of fetal malformation,

          -  Presence of conditions such as preeclampsia, multiparity, preterm labor

          -  History of adverse reaction to α-2 adrenergic agonists

          -  Nicotine addiction

          -  Chronic use of opioid
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudia Claroni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fatebenefratelli San Giovanni Calibita - Tiberine Island</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria Grazia Frigo, MD</last_name>
    <phone>+39066837258</phone>
    <email>mariagrazia.frigo@fbf-isola.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>San Giovanni Calibita Fatebenefratelli, Tiberine Island, Hospital</name>
      <address>
        <city>Rome</city>
        <zip>00186</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marco Aversano, MD</last_name>
      <phone>+39066837258</phone>
      <email>m.aversano@me.com</email>
    </contact>
    <investigator>
      <last_name>Claudia Claroni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2017</study_first_submitted>
  <study_first_submitted_qc>January 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2017</study_first_posted>
  <last_update_submitted>April 25, 2017</last_update_submitted>
  <last_update_submitted_qc>April 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>clonidine, spinal injections</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clonidine</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

